Qian Y. Gou
Yangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
CD47/SIRPα Axis in Cancer Immunotherapy: Mechanisms, Regulation, and Therapeutic Strategies.
Journal: European journal of pharmacology
Published: April 05, 2026
Ubiquitination of CD47 Regulates Innate Anti-Tumor Immune Response.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 01, 2024
PPARα phosphorylation regulates colorectal tumor immune escape.
Journal: The Journal of biological chemistry
Published: January 06, 2024
Inhibition of CK2/ING4 Pathway Facilitates Non-Small Cell Lung Cancer Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 20, 2023
PPARγ inhibited tumor immune escape by inducing PD-L1 autophagic degradation.
Journal: Cancer science
Published: January 16, 2023
PD-L1 degradation pathway and immunotherapy for cancer.
Journal: Cell death & disease
Published: August 09, 2020
EGFR/PPARδ/HSP90 pathway mediates cancer cell metabolism and chemoresistance.
Journal: Journal of cellular biochemistry
Published: July 17, 2020
PPARα agonist alleviates tumor growth and chemo-resistance associated with the inhibition of glucose metabolic pathway.
Journal: European journal of pharmacology
Published: July 28, 2019
Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells.
Journal: European journal of pharmacology
Published: March 03, 2019
Drug susceptibility test guided therapy and novel empirical quadruple therapy for Helicobacter pylori infection: a network Meta-analysis
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: June 28, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026